Literature DB >> 25477024

Enhancing DNA electro-transformation efficiency on a clinical Staphylococcus capitis isolate.

Bintao Cui1, Peter M Smooker1, Duncan A Rouch1, Margaret A Deighton2.   

Abstract

Clinical staphylococcus isolates possess a stronger restriction-modification (RM) barrier than laboratory strains. Clinical isolates are therefore more resistant to acceptance of foreign genetic material than laboratory strains, as their restriction systems more readily recognize and destroy foreign DNA. This stronger barrier consequently restricts genetic studies to a small number of domestic strains that are capable of accepting foreign DNA. In this study, an isolate of Staphylococcus capitis, obtained from the blood of a very low birth-weight baby, was transformed with a shuttle vector, pBT2. Optimal conditions for electro-transformation were as follows: cells were harvested at mid-log phase, electro-competent cells were prepared; cells were pre-treated at 55°C for 1min; 3μg of plasmid DNA was mixed with 70-80μL of competent cells (3-4×10(10)cells/mL) at 20°C in 0.5M sucrose, 10% glycerol; and electroporation was conducted using 2.1kV/cm field strength with a 0.1cm gap. Compared to the conventional method, which involves DNA electroporation of Staphylococcus aureus RN4220 as an intermediate strain to overcome the restriction barrier, our proposed approach exhibits a higher level (3 log10 units) of transformation efficiency. Heat treatment was used to temporarily inactivate the recipient RM barrier. Other important parameters contributing to improved electro-transformation efficiency were growth stage for cell harvesting, the quantity of DNA, the transformation temperature and field strength. The approach described here may facilitate genetic manipulations of this opportunistic pathogen.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biofilm; Cell competency; Electroporation; Restriction–modification barrier; Staphylococcus capitis; Transformation efficiency

Mesh:

Substances:

Year:  2014        PMID: 25477024     DOI: 10.1016/j.mimet.2014.11.012

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  6 in total

1.  Toxin-Triggered Interleukin-1 Receptor Signaling Enables Early-Life Discrimination of Pathogenic versus Commensal Skin Bacteria.

Authors:  John M Leech; Miqdad O Dhariwala; Margaret M Lowe; Kevin Chu; Geil R Merana; Clémence Cornuot; Antonin Weckel; Jessica M Ma; Elizabeth G Leitner; Jeanmarie R Gonzalez; Kimberly S Vasquez; Binh An Diep; Tiffany C Scharschmidt
Journal:  Cell Host Microbe       Date:  2019-11-26       Impact factor: 21.023

2.  Construction of Gpm6a/ReelinGFPCreERT2 by BAC recombination using a specific gene in hepatic mesothelial or stellate cells.

Authors:  Hong-Bo Shi; Jin-Li Lou; Hong-Lin Shi; Feng Ren; Yu Chen; Zhong-Ping Duan
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

3.  mazEF Homologue Has a Minor Role in Staphylococcus epidermidis 1457 Virulence Potential.

Authors:  Vânia Gaio; Tânia Lima; Manuel Vilanova; Nuno Cerca; Angela França
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

4.  Room temperature electrocompetent bacterial cells improve DNA transformation and recombineering efficiency.

Authors:  Qiang Tu; Jia Yin; Jun Fu; Jennifer Herrmann; Yuezhong Li; Yulong Yin; A Francis Stewart; Rolf Müller; Youming Zhang
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

5.  Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference.

Authors:  Yusuke Sato'o; Junzo Hisatsune; Liansheng Yu; Tetsushi Sakuma; Takashi Yamamoto; Motoyuki Sugai
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

6.  The optimization system for preparation of TG1 competent cells and electrotransformation.

Authors:  Dafei Chai; Gang Wang; Lin Fang; Huizhong Li; Shanshan Liu; Haiying Zhu; Junnian Zheng
Journal:  Microbiologyopen       Date:  2020-05-11       Impact factor: 3.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.